Senior Specialist, Global Pharmacovigilance - Animal Health

At Merck & Co., we are looking for a highly motivated and results-oriented Senior Specialist to join our Global Pharmacovigilance team in Animal Health. As the Senior Specialist, you will be a key player in the oversight of our Animal Health portfolio, which is critical to the success of our company.This is an excellent opportunity for an experienced professional with a strong background in pharmacovigilance and animal health to make an immediate impact. The successful candidate must have a keen eye for detail and be able to thrive in a fast-paced environment.The ideal candidate will possess a strong knowledge of pharmacovigilance principles and regulations, along with a thorough understanding of animal health products and their implications. The Senior Specialist must also have excellent communication and interpersonal skills, as they will be expected to work together with a global team of experts to ensure the highest standards of safety and efficacy for our products.We are seeking a highly organized and motivated individual with a minimum of a Bachelor's degree in a relevant scientific field, such as Animal Health or Veterinary Medicine. At least 5 years of professional experience in a pharmacovigilance or animal health position is also required.

According to JobzMall, the average salary range for a Senior Specialist, Global Pharmacovigilance - Animal Health in Madison, NJ 07940, USA is $75,000 to $95,000 per year.

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Alliances and Healthcare Services. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures.